Britain counters brain-drain worries  by Williams, Nigel
It is something of a paradox that
Britain is undoubtedly home to some
of the world’s leading researchers but
there are widespread rumblings of
dissatisfaction about the conditions
many people face and a continuing
trickle of top-level scientists leave for
posts overseas as a result. While talk
of a ‘brain-gain’ is never officially
acknowledged, the problem has been
serious enough to merit action by the
funding bodies to try to help
scientists work here. And a new
£20 million scheme launched this
summer aims to help around a
further 70 key researchers to remain
firmly at their British benches.
Just how effective some of
Britain’s leading biologists are was
revealed in a recent study carried out
for a national newspaper. The
newspaper looked at citiations to
papers published by researchers at
the Medical Research Council’s
Laboratory of Molecular Biology
(LMB) in Cambridge. The lab’s
papers turned out to be most
frequently cited by the world’s
biomedical researchers during the
late 1990s. On average, each of the
LMB’s papers was cited over
36 times, more than seven times the
world average, the survey found.
Success is not confined to the
research council labs. UK universities
are assessed for the quality of their
research in the massive Research
Assessment Exercise (RAE) which
looks at publications department by
department. A significant number
achieve top marks, showing that they
are carrying out work of the highest
international standards.
But these findings are small fry in
global biomedical research. The
same newspaper survey found that
Harvard alone produced 100 times
the number of biomedical articles
published by the LMB between
1994–1998 — more than Cambridge,
Oxford and University College
London put together. 
That Britain is such a small global
player is not the only problem. The
aim of the RAE is to award more
research funds through the
universities to the best departments
but the scheme works against a
backdrop of a chronic shortage of
university research funds that all
researchers are only too aware of.
However generous funding agencies
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are, without university cash to back-
up grants, researchers face problems.
Along with the cash-strapped
universities, many researchers also
feel underpaid, particularly compared
with colleagues in the US, and that
their position also awards them with
comparatively low status compared
with other professions. In varying
proportions, these are the often-cited
reasons key scientists leave the
country. And it’s an awareness of
these problems that has prompted
the latest scheme. Dubbed a ‘brain
gain’ scheme, the new awards are
funded by the government’s
Department of Trade and Industry
and the Wolfson Foundation, an
independent private charity. They
are administered by the Royal
Society, Britain’s science academy,
and provide a cash boost over five
years that can be spent as the
recipient chooses. The new awards
“send a message across the globe that
Britain remains one of the best places
to carry out scientific research,” says
Royal Society president, Robert May. 
For David Goldstein, one of the
two biologists to win an award
amongst the first seven announced
this summer, it has come at a time
when he was beginning to consider
his future in this country. Goldstein,
who works on human genetic
variation at University College
London, has been in the UK for five
years. He is impressed with the
funding agencies and believes they
are funding well and in often creative
ways. But the key problem he and so
many of his colleagues find is that
the universities are not able to keep
up. “In the US, universities can be
more flexible and imaginative
because they have their own funds,”
he says. Many can afford to invest
substantial sums, for example to
create a new institute and bring key
people together, he adds. 
Very small amounts of
discretionary funding can have a
quite disproportionately large
impact
In such a fast-moving field as human
genetics, he also finds that the lack of
flexibility to take up new lines of
research quickly within the
conventional grants system creates a
potential block to his group’s
competitiveness. But this is where
the new award, given without
conditions, is particularly valuable.
Goldstein says he’ll be spending
most of the new money on
consumables. “I’ve already got very
good people,” he says.”
“Even very small amounts of
discretionary funding can have a
quite disproportionately large impact
on a research programme by
providing key flexibility to try new
things quickly,” he says.
And Britain has proved to have
one or two advantages for his field of
work. “We work with samples from
all over the world, but in Britain
people are more relaxed about
genetic studies of the population
than in the US,” he says. Indeed, he
has one project looking at the genetic
impact of the Viking invasions of
Britain. It is being followed by a
television crew with the aim of
producing a programme for which
there is likely to be a great deal more
public curiosity than concern.
While Goldstein and colleagues
may now be enjoying key additional
funding to help them remain working
in Britain, the awards have come too
late for the likes of Gerard Evan, who
left Britain in 1999 to work at the
Comprehensive Cancer Center at
University of California at San
Francisco. Wooed by new scientific
opportunities, a bigger salary, higher
status and an appealing lifestyle, he
and many other Britons have flocked
to the US. Indeed, at the Center,
around a quarter of the labs are run
by Britons and many of the post-docs
are also British. 
Evan, formerly of the Imperial
Cancer Research Fund, became
disillusioned with the pay, prospects
and daily grind of commuting into
central London. He soon became
aware of differences between life and
work in the US compared with
Britain. People work very hard in the
US but the difference in quality of
life is substantial, he says. But he also
notices differing scientific attitudes.
There’s an emphasis on work that
will lead to publications, whereas in
Britain he believes there is more
support for people who ‘rattle the
cages’ of established thinking.
In Goldstein’s case the award has
helped keep a successful researcher
in Britain for the next few years, as is
the likely outcome of  other ‘brain-
gain’ awards to be announced later
this year and in 2002. While this new
scheme may well turn out to be a
success, other schemes may be
necessary to attract back some of the
key people now working abroad who
may wish sometime in the future to
return to the UK and to support
others who may like the chance to
work in the country.
Award winner: David Goldstein of University
College London has won one of a new set of
`brain gain’ awards which provides him with
funds to help him continue working in the UK
and boost his work on human genetics. 
